Upregulation of histidine decarboxylase mRNA expression in scleroderma skin

[1]  N. Koibuchi,et al.  Quantitative analysis of α1(I) and α1(III) procollagen mRNA expression in systemic sclerosis skin tissue – an in situ hybridization study , 1999, Archives of Dermatological Research.

[2]  H. Kim,et al.  Role of TGF-beta 1 on the IgE-dependent anaphylaxis reaction. , 1999, Journal of immunology.

[3]  C. Salmaso,et al.  Reduced priming effect of interleukin 3 on IgE mediated basophil histamine release in patients with systemic sclerosis. , 1998, The Journal of rheumatology.

[4]  C. Prinz,et al.  Functional Importance of Synaptobrevin and SNAP-25 during Exocytosis of Histamine by Rat Gastric Enterochromaffin-Like Cells , 1997 .

[5]  T. Ahmed,et al.  Heterogeneity of allergic airway responses in sheep: differences in signal transduction? , 1996, American journal of respiratory and critical care medicine.

[6]  E. Lindström,et al.  Depletion of enterochromaffin-like cell histamine increases histidine decarboxylase and chromogranin A mRNA levels in rat stomach by a gastrin-independent mechanism. , 1996, Scandinavian journal of gastroenterology.

[7]  J. Thibault,et al.  Monocyte chemotactic protein-1 provokes mast cell aggregation and [3H]5HT release. , 1995, Immunology.

[8]  M. Hebbar,et al.  E-selectin expression in salivary endothelial cells and sera from patients with systemic sclerosis. Role of resident mast cell-derived tumor necrosis factor alpha. , 1995, Arthritis and rheumatism.

[9]  N. Koibuchi,et al.  In Situ Hybridization Detection of TSHβ Subunit Gene Expression in the Serum‐Free Primary Culture of the Adult Rat Pituitary , 1994, Journal of neuroendocrinology.

[10]  J. Bousquet,et al.  Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung. , 1993, The American review of respiratory disease.

[11]  L. Schwartz,et al.  Mast cell changes in scleroderma , 1992 .

[12]  G. Valentini,et al.  Human basophil releasability. VIII. Increased basophil releasability in patients with scleroderma. , 1991, Arthritis and rheumatism.

[13]  J. Seibold,et al.  Dermal mast cell degranulation in systemic sclerosis. , 1990, Arthritis and rheumatism.

[14]  D. Pfaff,et al.  Expression of NGF receptor in the rat forebrain detected with in situ hybridization and immunohistochemistry. , 1989, Brain research. Molecular brain research.

[15]  H. Claman.  On scleroderma. Mast cells, endothelial cells, and fibroblasts. , 1989, JAMA.

[16]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[17]  K. Nishioka,et al.  Mast cell numbers in diffuse scleroderma. , 1987, Archives of dermatology.

[18]  M. Condorelli,et al.  Human basophil releasability. I. Age-related changes in basophil releasability. , 1986, The Journal of allergy and clinical immunology.

[19]  R. Clark,et al.  Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? , 1985, Annals of internal medicine.

[20]  A. Riccio,et al.  Plasma free aminoacids pattern in progressive systemic sclerosis. , 1984, Bollettino della Societa italiana di biologia sperimentale.

[21]  A. Masi.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[22]  James F. Fries,et al.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.

[23]  M. Fujimoto,et al.  Elevated procollagen type I carboxyterminal propeptide production in cultured scleroderma fibroblasts. , 1995, Dermatology.

[24]  L. Schwartz,et al.  Mast cell changes in scleroderma. Presence of MCT cells in the skin and evidence of mast cell activation. , 1992, Arthritis and rheumatism.

[25]  D. Pfaff,et al.  [6] - In Situ Hybridization: A Methodological Guide , 1989 .